Valion Bio, Inc.

NasdaqCM:VBIO Stock Report

Market Cap: US$2.1m

Valion Bio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:VBIO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Sep 26BuyUS$8,6543i FundCompany3,004US$2.88
25 Aug 26BuyUS$20,8873i FundCompany5,308.08US$3.94
24 Aug 26SellUS$55,1583i FundCompany17,734.44US$4.41
19 Aug 26SellUS$430,5733i FundCompany110,823.68US$4.50
12 Aug 26SellUS$54,462Maier TarlowIndividual1,969.68US$27.65
24 Jul 26SellUS$86,2753i FundCompany5,796.76US$26.23
25 Jun 26SellUS$368,453Maier TarlowIndividual20,789.52US$20.43
22 Jun 26BuyUS$5,0093i FundCompany388.12US$12.91
11 Jun 26BuyUS$69,080Maier TarlowIndividual5,160US$13.39
03 Jun 26BuyUS$6,280Maier TarlowIndividual400US$15.70
15 Apr 26BuyUS$10,400Sheryle BoltonIndividual400US$26.00
01 Apr 26BuyUS$18,008Christina ValauriIndividual760US$23.70

Insider Trading Volume

Insider Buying: VBIO insiders have sold more shares than they have bought in the past 3 months.

Ownership Breakdown

What is the ownership structure of VBIO?
Owner TypeNumber of SharesOwnership Percentage
Public Companies2,4480.276%
Individual Insiders5,5680.627%
Institutions125,78614.2%
General Public753,78784.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1309.6%.

Top Shareholders

Top 23 shareholders own 15.07% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.2%
3i Fund
90,252US$216.6k2,010%2.28%
1.98%
EOM Management, Ltd.
17,610US$42.3k0%no data
0.52%
Murchinson Ltd.
4,600US$11.0k0%0.01%
0.44%
Jennifer Ernst
3,924US$9.4k200%no data
0.33%
Citadel Advisors LLC
2,965US$7.1k0%no data
0.28%
Biostax Corp.
2,448US$5.9k0%no data
0.28%
Sanctuary Advisors, LLC
2,448US$5.9k0%no data
0.24%
Marex Group Limited
2,171US$5.2k-8.4%no data
0.23%
Avenue Capital Group, LLC
2,005US$4.8k0%1.72%
0.18%
Virtu Financial, Inc.
1,569US$3.8k0%no data
0.087%
Geode Capital Management, LLC
774US$1.9k-78%no data
0.086%
Christina Valauri
760US$1.8k0%no data
0.052%
Hudson River Trading LLC
458US$1.1k-73%no data
0.05%
UBS Asset Management AG
443US$1.1k371%no data
0.05%
Michael Handley
441US$1.1k24.9%no data
0.046%
Two Sigma Securities, LLC
406US$974.40%no data
0.045%
Sheryle Bolton
400US$960.10%no data
0.0094%
Tower Research Capital Europe Limited
83US$199.2261%no data
0.0028%
Lisa Wolf
25US$60.119.1%no data
0.002%
Kimberly Bambach
18US$43.20%no data
0.00011%
The Toronto-Dominion Bank
1US$2.30%no data
0.00011%
SBI Holdings, Inc.
1US$2.30%no data
0.00011%
Caitong International Asset Management Co., Limited
1US$2.30%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/10 04:33
End of Day Share Price 2026/09/10 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Valion Bio, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hunter DiamondDiamond Equity Research LLC